Peter E. Boyd Aquestive Therapeutics, Inc. (AQST) insider trading activity

Peter E. Boyd is See Remark of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 303,323 shares of AQST, which is worth approximately $870,537. The most recent transaction as insider was on Mar 09, 2025, when has been sold 7,681 shares (Common Stock) at a price of $2.65 per share, resulting in proceeds of $20,354. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 303K

27.65% 3M change

27.65% 12M change

Total Value Held $870,537

Peter E. Boyd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 09 2025	SELL Payment of exercise price or tax liability	$20,354 $2.65 p/Share	7,681 Reduced 2.47%	303,323 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$17,553 $2.65 p/Share	6,624 Reduced 2.09%	311,004 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	80,000 Added 20.12%	317,628 Common Stock
Mar 09 2024	SELL Payment of exercise price or tax liability	$40,845 $4.88 p/Share	8,370 Reduced 3.4%	237,628 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	86,250 Added 25.96%	245,998 Common Stock
Mar 09 2023	BUY Grant, award, or other acquisition	-	100,000 Added 38.53%	159,532 Common Stock
Jun 14 2022	BUY Open market or private purchase	$4,050 $0.81 p/Share	5,000 Added 7.75%	59,532 Common Stock
Jun 08 2022	BUY Open market or private purchase	$2,201 $0.96 p/Share	2,293 Added 4.04%	54,532 Common Stock

PEB

Peter E. Boyd

See Remark

Warren, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Value

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST

Account